HPAPIs (Highly Potent APIs)
Mastery of the Potent Frontier: Secure Your HPAPI & ADC Pipeline
Mastery of the Potent Frontier: Secure Your HPAPI & ADC Pipeline
HPAPIs (Highly Potent APIs)
India's HPAPI ecosystem is world-class, but navigating it demands more than capacity claims. Hidden risks - from inconsistent maintenance cultures to ultra-trace cross-contamination - separate successful programs from costly failures.
Aventiq Bio acts as your sentinel: independent, on-ground, and technically rigorous.
-
Shadow Capacity Claims:
Many facilities advertise OEB 5 but lack sustained maintenance cultures, leading to gradual containment degradation
-
Ultra-Trace Detection Failures:
Standard analytics miss low-ppm contamination, causing batch rejections or recalls
-
Waste Stream Liability:
Increasing global scrutiny on toxic waste handling in emerging markets - exposing sponsors to reputational and legal risk
-
Tech Transfer Fragility:
Potent charging/discharging phases prone to exposure during scale-up
-
Regulatory Ambush:
Heightened focus on Category 4–5 compounds resulting in 483s, import alerts, or delayed approvals.
The Hidden Risks That Derail HPAPI Programs
The Aventiq Sentinel: Functional Oversight for Zero-Error HPAPI Programs
The HPAPI Life-Cycle Guard – Our Functional Oversight
Partner Vetting Extreme Containment Due Diligence
Beyond paper audits: Verification of isolator integrity, pressure logs, and cleaning validation history
Tech Transfer Cross-Contamination Mapping
Custom cleaning validation strategies to prevent ppm-level carryover
Analytical Ultra-Trace Method Governance
Oversight of specialized methods (LC-MS, ICP-MS) for sub-ppm detection
On-Ground The Sentinel (Person-in-Plant)
Dedicated oversight during high-risk phases (charging, sampling, discharging)
Potent Peptides Support
Potent Peptide Synthesis Oversight
Contained solid-phase synthesis for cytotoxic or high-potency peptides
Integration with ADC/Oncology
Peptide payloads or cleavable linkers for conjugates under extreme containment
-
This bridges our HPAPI strength with peptide programs - critical for next-generation oncology therapeutics.
Why Aventiq Bio – The Sentinel Difference
Many potent peptides fall under HPAPI classification (OEB 4–5 due to cytotoxicity). We extend our extreme containment expertise to these programs, ensuring safe synthesis, scale-up, and integration - particularly for oncology and ADC applications.
Proprietary database of truly OEB 5-capable facilities (maintenance-verified)
Sentinel on-site teams with oncology payload expertise
Predictive containment & waste liability risk models
True independence - your firewall, not a broker
Aventiq Bio enforces zero-exposure protocols, ALCOA+ data integrity, and full waste stream accountability - delivering Western-executive confidence in every potent program.